Charles N York II
CIK 1655962 · View on SEC EDGAR ↗
First SEC filing: April 6, 2016 · Latest: April 6, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2017 | SYRE | P | 10,241 | $4.76 | $48,747 | 34,787 Direct | +41.72% | Acquired | -8.3% (price as of 2026-08-21) |
| Dec. 4, 2017 | SYRE | P | 3,259 | $4.97 | $16,197 | 24,546 Direct | +15.31% | Acquired | -12.1% (price as of 2026-08-21) |
| Dec. 1, 2017 | SYRE | P | 6,500 | $4.59 | $29,835 | 21,287 Direct | +43.96% | Acquired | -4.9% (price as of 2026-08-21) |
| Aug. 15, 2017 | SYRE | P | 1,959 | $2.52 | $4,937 | 14,787 Direct | +15.27% | Acquired | 73.3% (price as of 2026-08-21) |
| Feb. 15, 2017 | SYRE | P | 2,000 | $4.28 | $8,560 | 12,828 Direct | +18.47% | Acquired | 2.0% (price as of 2026-08-21) |
| Aug. 15, 2016 | SYRE | P | 2,000 | $3.99 | $7,980 | 10,828 Direct | +22.66% | Acquired | 9.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 20, 2018 | SYRE | Employee Stock Option (right to buy) | Common Stock (92,100) | $6.31 | Feb. 19, 2028 | 92,100 | Acquired |
| Aug. 22, 2017 | SYRE | Employee Stock Option (right to buy) | Common Stock (58,500) | $3.10 | Aug. 21, 2027 | 58,500 | Acquired |
| March 20, 2017 | SYRE | Employee Stock Option (right to buy) | Common Stock (90,000) | $8.03 | March 19, 2027 | 90,000 | Acquired |
| May 17, 2016 | SYRE | Employee Stock Option (right to buy) | Common Stock (55,000) | $7.28 | May 16, 2026 | 55,000 | Acquired |
| April 12, 2016 | SYRE | Series B Preferred Stock | Common Stock (2,037) | — | — | 2,037 | Disposed |
| April 12, 2016 | SYRE | Series A Preferred Stock | Common Stock (9,523) | — | — | 9,523 | Disposed |
| April 12, 2016 | SYRE | Series B Preferred Stock | Common Stock (1,324) | — | — | 1,324 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 6, 2016 | SYRE | Common Stock | 7,504 | Direct |
| April 6, 2016 | SYRE | Series A Preferred Stock→ Common Stock (9,523) | 9,523 | Indirect |
| April 6, 2016 | SYRE | Series B Preferred Stock→ Common Stock (2,037) | 2,037 | Indirect |
| April 6, 2016 | SYRE | Series B Preferred Stock→ Common Stock (1,324) | 1,324 | Direct |
| April 6, 2016 | SYRE | Employee Stock Option (right to buy)→ Common Stock (10,183) | 10,183 | Direct |
| April 6, 2016 | SYRE | Employee Stock Option (right to buy)→ Common Stock (22,258) | 22,258 | Direct |
| April 6, 2016 | SYRE | Employee Stock Option (right to buy)→ Common Stock (15,027) | 15,027 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $415,000 | — | — | — | — | — | $8,053 | $1,283,468 |
| 2019 | $390,000 | — | — | — | $165,000 | — | $7,712 | $1,085,136 |
| 2018 | $343,000 | $185,000 | — | — | — | — | $7,981 | $960,823 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.